...
首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002
【24h】

Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, Tat and AT-1002

机译:使用功能性肽Tat和AT-1002开发有效的小分子干扰RNA透皮递送系统

获取原文
获取原文并翻译 | 示例
           

摘要

Topical use of small interfering RNA (siRNA) as a therapeutic nucleic acid is increasingly studied for the treatment of skin diseases and for the improvement of skin properties. However, naked siRNA transdermal delivery is limited by its low stability in the body and low permeability into target cells. This is due to various skin barriers such as the stratum corneum that has multiple lipid bilayers and epidermal layers that have tight junctions. In this study, we investigate non-invasive transdermal siRNA delivery using two functional peptides: AT1002, which is a tight junction modulator and 6-mer synthetic peptide belonging to a novel class of compounds that reversibly increases paracellular transport of molecules across the epithelial barrier; and Tat, which is a cell-penetrating peptide applicable as a transdermal siRNA delivery enhancer. We examined whether expression of the tight junction protein zonula occludens protein 1 (ZO-1) was detected in mouse skin applied with AT1002. Additionally, siRNA stabilities for RNaseA using Tat and AT1002 were assessed. We also determined the intradermal delivery efficiency of siRNA using functional peptides by confocal laser microscopy of fluorescently labeled siRNA in mouse skin. We found that the Tat analog and AT1002 strongly increased siRNA stability against RNaseA. In addition, ZO-1 disappeared from the skin after treatment with AT1002, yet recovered with time after washing. Finally, we also found that Tat and AT1002 peptides accelerate transdermal siRNA delivery both widely and effectively. Thus, combination of Tat and AT1002 is expected to be a transdermal delivery enhancer of siRNA.
机译:越来越多地研究了小干扰RNA(siRNA)作为治疗性核酸的局部使用,以治疗皮肤疾病和改善皮肤特性。但是,裸露的siRNA透皮递送受到其在体内的低稳定性和对靶细胞的低渗透性的限制。这是由于各种皮肤屏障,例如具有多个脂质双层的角质层和具有紧密连接的表皮层。在这项研究中,我们研究了使用两种功能性肽的无创性透皮siRNA传递:AT1002是紧密连接调节剂,是6-mer合成肽,属于新型化合物,可逆地增加分子通过上皮屏障的旁细胞转运; Tat是一种细胞穿透肽,可用作透皮siRNA传递增强剂。我们检查了在使用AT1002的小鼠皮肤中是否检测到紧密连接蛋白小带闭合蛋白1(ZO-1)的表达。此外,评估了使用Tat和AT1002的RNaseA的siRNA稳定性。我们还通过共聚焦激光显微镜对小鼠皮肤中荧光标记的siRNA使用功能性肽段确定了siRNA的皮内递送效率。我们发现,Tat类似物和AT1002大大提高了针对RNaseA的siRNA稳定性。此外,ZO-1在用AT1002处理后从皮肤上消失,但在清洗后随时间恢复。最后,我们还发现Tat和AT1002肽可广泛有效地促进透皮siRNA的递送。因此,Tat和AT1002的组合有望成为siRNA的透皮递送增强剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号